How to appeal a Cigna substance use disorder treatment (sud/moud) denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for substance use disorder treatment (sud/moud)

Cited policy: Cigna / Evernorth BH SUD Treatment Coverage Policy + Vivitrol/Sublocade MAT policies

90-day initial rental, then compliance review. Often requires oral naltrexone trial before Vivitrol.

How Cigna denies substance use disorder treatment (sud/moud) — and how to counter it

Where Cigna pushes back: 1) Sublocade PA requires 7-day stabilization; 2) Vivitrol denied — oral naltrexone trial required first; 3) Residential SUD denied; 'ASAM 2.5 PHP appropriate'.

Counter-arguments that hold up: X:BOT (Lee 2018) — XR-naltrexone induction barrier eliminates oral trial requirement; once initiated, equivalent outcomes. ASAM 4e Dim 4/6 justifies LAI over oral. Parity: medical/surgical equivalents (depot antipsychotic, GLP-1 injectables) don't require oral failure — SUD step-edit is NQTL violation.

What Cigna typically denies for substance use disorder treatment (sud/moud)

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For substance use disorder treatment (sud/moud), expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the substance use disorder treatment (sud/moud) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Suboxone (subli)
• Sublocade LA
• Brixadi LA
• Methadone OTP
• Vivitrol LA
• Naltrexone PO

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.